Heart Failure: Therapeutic Updates

Therapeutic updates in heart failure management have revolutionized patient care. Novel treatments, such as angiotensin receptor-neprilysin inhibitors (ARNIs), sodium-glucose co-transporter-2 inhibitors (SGLT2 inhibitors), and cardiac resynchronization therapy (CRT), have shown remarkable benefits in reducing hospitalizations, improving symptoms, and prolonging survival. Continuous research aims to optimize therapeutic options and enhance outcomes for heart failure patients.

    Related Conference of Heart Failure: Therapeutic Updates

    November 27-28, 2025

    32nd World Heartcare Summit

    Paris, France
    January 12-13, 2026

    12th International Heart Conference

    Dubai, UAE
    March 18-19, 2026

    15th World Heart Congress

    Paris, France
    March 23-24, 2026

    41st World Cardiology Conference

    London, UK
    April 08-29, 2026

    9th Annual Heart Rhythm Conference

    Vienna, Austria
    April 13-14, 2026

    9th World Heart and Brain Conference

    Tokyo, Japan
    May 14-15, 2026

    5th International Conference on Cardiology

    Rome, Italy
    May 21-22, 2026

    15th World Congress on Cardiology

    London, UK
    July 29-30, 2026

    30th World Cardiology Conference

    Paris, France

    Heart Failure: Therapeutic Updates Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in